Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Medical Hypotheses|February 21, 2004
The "Yoking" of glutamatergic brain mechanisms involved in controlling brain neuronal excitability and psychosis to brain mechanisms involved in appetite regulation: a new hypothesis on the origin of psychosisRichard B Rosse, Stephen I DeutschClinical Neuropharmacology|November 1, 2002
Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophreniaRichard B Rosse, Stephen I DeutschBehavioural Brain Research|July 22, 2004
Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophreniaJohn Mastropaolo, Richard B Rosse, Stephen I DeutschSchizophrenia Research|April 22, 2004
A quantitative measure of postural sway deficits in schizophreniaCherie L Marvel, Barbara L Schwartz, Richard B RosseClinical Neuropharmacology|December 3, 2009
Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramateStephen I Deutsch, Jessica A Burket, Richard B RosseEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 2006
Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's diseaseStephen I Deutsch, Richard B Rosse, Lynn H DeutschProgress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2006
Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implicationsStephen I Deutsch, Richard B Rosse, Raj M LakshmanCNS Spectrums|December 29, 2007
Williams syndrome: a genetic deletion disorder presenting clues to the biology of sociability and clinical challenges of hypersociabilityStephen I Deutsch, Richard B Rosse, Barbara L SchwartzClinical Neuropharmacology|October 2, 2003
Progressive worsening of adaptive functions in Down syndrome may be mediated by the complexing of soluble Abeta peptides with the alpha 7 nicotinic acetylcholine receptor: therapeutic implicationsStephen I Deutsch, Richard B Rosse, John Mastropaolo, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 18, 2006
Exogenously administered D-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed miceKatrice D Long, John Mastropaolo, Richard B Rosse, et al.Pageof 5